Cargando…
Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
Primary hepatocellular carcinoma (HCC) mainly develops in subjects chronically infected with hepatitis B (HBV) and C (HCV) viruses through a multistep process characterized by the accumulation of genetic alterations in the human genome. Nucleotide changes in coding regions (i.e. TP53, CTNNB1, ARID1A...
Autores principales: | Pezzuto, Francesca, Buonaguro, Luigi, Buonaguro, Franco M., Tornesello, Maria Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437489/ https://www.ncbi.nlm.nih.gov/pubmed/28529542 http://dx.doi.org/10.1186/s13027-017-0138-5 |
Ejemplares similares
-
Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2016) -
Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2021) -
The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2018) -
Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations
por: Tornesello, Maria Lina, et al.
Publicado: (2023) -
Mutations in the telomerase reverse transcriptase promoter and PIK3CA gene are common events in penile squamous cell carcinoma of Italian and Ugandan patients
por: Starita, Noemy, et al.
Publicado: (2022)